Innovative Industrial Properties Reports First Quarter 2026 Results
Executed Leases for 389,000 Square Feet Year-To-Date
Executive Chairman Remarks
“We are encouraged by the pace of leasing activity year-to-date, including nearly 400,000 square feet of executed leases, which underscores the ongoing demand for our properties," said
First Quarter 2026 and Second Quarter to Date Highlights
Financial Results and Dividend
-
Total revenues of
$69.0 million and net income attributable to common stockholders of$30.2 million , or$1.02 per diluted share (all per share amounts in this press release are reported on a diluted basis unless otherwise noted). -
Adjusted funds from operations ("AFFO") of
$53.4 million , or$1.88 per share. -
Declared dividends to common stockholders totaling
$1.90 per share. Since its inception, IIP has paid over$1.1 billion in common stock dividends to its stockholders.
|
|
Three Months Ended |
|
Three Months Ended |
|||||||||
|
|
|
|
|
|||||||||
|
(in thousands, except per share amounts) |
Amount |
|
Per Share |
|
Amount |
|
Per Share |
|||||
|
Net income attributable to common stockholders |
$ |
30,155 |
|
$ |
1.02 |
|
$ |
30,296 |
|
$ |
1.03 |
|
|
Normalized FFO |
|
50,585 |
|
|
1.78 |
|
|
52,761 |
|
|
1.85 |
|
|
AFFO |
|
53,434 |
|
|
1.88 |
|
|
55,332 |
|
|
1.94 |
|
|
__________________________________________________________________ |
||||
|
Definitions of the above-mentioned non-GAAP financial measures, together with reconciliations to net income in accordance with GAAP and other definitions of capitalized terms used herein, appear at the end of this release. |
||||
-
As of
March 31, 2026 , the Company had funded an aggregate of$150.0 million of its strategic investment inIQHQ, Inc. , consisting of a fully funded$100.0 million revolving credit facility and$50.0 million of Series G preferred equity. Subsequent to quarter end, the Company funded an additional$25.0 million of Series G preferred equity. The Company remains committed to funding up to an additional$95.0 million of preferred equity, in multiple tranches through the second quarter of 2027.
Portfolio - Leasing
-
In
January 2026 , executed a 204,000 square foot full-building lease inDesert Hot Springs, California with Gramlin, a privateCalifornia operator. -
In
March 2026 , executed a 5,000 square foot lease inPalm Springs, California . -
In
March 2026 , executed a 56,000 square foot full-building lease inPalm Springs, California with Gramlin, a privateCalifornia operator. -
In
March 2026 , executed a 66,000 square foot full-building lease inDwight, Illinois with Grown Rogue, a public multi-state operator. -
In
April 2026 , executed a 58,000 square foot full-building lease inBuckeye Lake, Ohio with Curaleaf, a public multi-state operator.
Portfolio - Tenant Updates
- The following table summarizes payments received from certain defaulted tenants during the periods presented and the corresponding per share impact (in thousands, except per share amounts):
|
|
|
Three Months Ended
|
|
Three Months Ended
|
|
Q2'26 To Date |
||||||||||||
|
|
|
|
|
|||||||||||||||
|
Tenant |
|
Total Payments |
Per Share(1) |
|
Total Payments |
Per Share(1) |
|
Total Payments |
Per Share(1) |
|||||||||
|
Gold Flora |
|
$ |
3,738 |
$ |
0.13 |
|
$ |
1,500 |
$ |
0.05 |
|
$ |
— |
$ |
— |
|||
|
|
|
|
242 |
|
0.01 |
|
|
3,244 |
|
0.11 |
|
|
850 |
|
0.03 |
|||
|
4Front |
|
|
— |
|
— |
|
|
225 |
|
0.01 |
|
|
400 |
|
0.01 |
|||
|
Total |
|
$ |
3,980 |
$ |
0.14 |
|
$ |
4,969 |
$ |
0.17 |
|
$ |
1,250 |
$ |
0.04 |
|||
|
___________________________________________________________________ |
||
|
(1) |
For the three months ended |
|
-
PharmaCann -
During the first quarter of 2026, the
Ohio andPennsylvania courts released$1.7 million and$1.3 million , respectively, to the Company comprised of the rent payments previously required to be escrowed with the court byPharmaCann . -
As previously disclosed, the Company has resolved all pending litigation with
PharmaCann with respect toPharmaCann's prior lease defaults. The settlement agreement that the Company has entered into withPharmaCann includes monetary judgments for amounts owed byPharmaCann under the leases for NewYork, Ohio andPennsylvania and mandates the turnover of these properties to the Company byMay 20, 2026 for theNew York andPennsylvania properties and byMay 26, 2026 for theOhio property. -
As noted above in "Portfolio - Leasing", the Company has executed new leases for its properties in
Ohio andIllinois that were previously leased toPharmaCann .
-
During the first quarter of 2026, the
-
Gold Flora
-
During the first quarter of 2026, the Company received
$1.5 million in settlement of all remaining unpaid administrative rents due from the receivership. -
The Company has executed lease agreements for the three properties previously leased by Gold Flora, executing a lease agreement for its 70,000
Palm Springs property inNovember 2025 , executing a lease agreement for its 204,000 square footDesert Hot Springs property inJanuary 2026 , and executing a lease agreement for its 56,000 square footPalm Springs property inMarch 2026 .
-
During the first quarter of 2026, the Company received
-
4Front
-
The Company has reached tentative arrangements with prospective new tenants for the four assets leased to 4Front, including a 250,000 square foot asset in
Illinois , a 114,000 square foot asset inWashington , and two assets inMassachusetts totaling 124,000 square feet. Each of these arrangements is subject to customary diligence and licensing processes and are expected to go into effect at the conclusion of receivership proceedings, expected by year end 2026.
-
The Company has reached tentative arrangements with prospective new tenants for the four assets leased to 4Front, including a 250,000 square foot asset in
Balance Sheet Highlights (at
-
13% debt to total gross assets, with
$2.8 billion in total gross assets. -
Total liquidity was
$176.6 million , consisting of cash and cash equivalents (as reported in IIP’s consolidated balance sheet as ofMarch 31, 2026 ) and availability under IIP’s revolving credit facility. - Debt service coverage ratio of 11.6x (calculated in accordance with IIP’s 5.50% Unsecured Senior Notes due 2026).
Financing Activity
-
Preferred Stock
-
In total, the Company has raised
$70.9 million in net proceeds from preferred stock issuances year-to-date comprised of the following:-
During the quarter ended
March 31, 2026 , the Company issued 2,698,523 shares its of 9.00% Series A Preferred Stock under its ATM Program for$60.3 million in net proceeds. -
Subsequent to
March 31, 2026 , the Company issued an additional 506,628 shares of its 9.00% Series A Preferred Stock under its ATM Program for$10.6 million in net proceeds.
-
During the quarter ended
-
In total, the Company has raised
-
Common Stock
-
In total, the Company has raised
$34.9 million in net proceeds from common stock issuances year-to-date comprised of the following:-
During the quarter ended
March 31, 2026 , the Company issued 178,655 shares of its common stock under its ATM Program for$9.3 million in net proceeds. -
Subsequent to
March 31, 2026 , the Company issued an additional 514,950 shares of its common stock under its ATM Program for$25.6 million in net proceeds.
-
During the quarter ended
-
In total, the Company has raised
-
Note Repurchase
-
Subsequent to
March 31, 2026 , the Company repurchased$9.1 million of the Company’s 5.50% Unsecured Notes at a discount to par.
-
Subsequent to
-
Secured Debt
-
Subsequent to
March 31, 2026 , the Company closed on a$20.0 million , three-year secured term loan which bears interest at a fixed rate of 9.0%.
-
Subsequent to
Financial Results
For the three months ended
For the three months ended
For the three months ended
Dividend
On
Supplemental Information
Supplemental financial information is available in the Investor Relations section of IIP’s website at www.innovativeindustrialproperties.com.
Teleconference and Webcast
About
This press release contains statements that IIP believes to be “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than historical facts are forward-looking statements. When used in this press release, words such as IIP “expects,” “intends,” “plans,” “estimates,” “anticipates,” “believes” or “should” or the negative thereof or similar terminology are generally intended to identify forward-looking statements. Forward-looking statements in this press release include, but are not limited to, statements regarding potential transactions, including proposed leases of our properties and potential debt financings, the consummation of which remains subject to the negotiation and execution of definitive documentation, satisfaction of customary closing conditions and other contingencies, including those relating to receivership sale processes. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, such statements. You should not rely on forward-looking statements since they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond the Company's control and which could materially affect actual results, performances or achievements. Factors that may cause actual results to differ materially from current expectations include, but are not limited to, the risk factors discussed in the Company's most recent Annual Report on Form 10-K for the year ended
|
CONSOLIDATED BALANCE SHEETS (Unaudited) (In thousands, except share and per share amounts) |
||||||||
|
|
|
|
|
|
||||
|
Assets |
|
2026 |
|
2025 |
||||
|
Real estate, at cost: |
|
|
|
|
||||
|
Land |
|
$ |
145,104 |
|
|
$ |
146,320 |
|
|
Buildings and improvements |
|
|
2,269,439 |
|
|
|
2,269,597 |
|
|
Construction in progress |
|
|
40,311 |
|
|
|
40,593 |
|
|
Total real estate, at cost |
|
|
2,454,854 |
|
|
|
2,456,510 |
|
|
Less accumulated depreciation |
|
|
(361,093 |
) |
|
|
(343,062 |
) |
|
Net real estate held for investment |
|
|
2,093,761 |
|
|
|
2,113,448 |
|
|
Life science investments |
|
|
153,980 |
|
|
|
152,665 |
|
|
Construction loan receivable |
|
|
22,800 |
|
|
|
22,800 |
|
|
Cash and cash equivalents |
|
|
89,117 |
|
|
|
47,597 |
|
|
In-place lease intangible assets, net |
|
|
6,155 |
|
|
|
6,366 |
|
|
Other assets, net |
|
|
28,167 |
|
|
|
27,982 |
|
|
Total assets |
|
$ |
2,393,980 |
|
|
$ |
2,370,858 |
|
|
|
|
|
|
|
||||
|
Liabilities and stockholders’ equity |
|
|
|
|
||||
|
Liabilities: |
|
|
|
|
||||
|
Notes due 2026, net |
|
$ |
290,981 |
|
|
$ |
290,602 |
|
|
Revolving credit facilities |
|
|
75,000 |
|
|
|
102,500 |
|
|
Building improvements and construction funding payable |
|
|
851 |
|
|
|
2,964 |
|
|
Accounts payable and accrued expenses |
|
|
14,702 |
|
|
|
10,870 |
|
|
Dividends payable |
|
|
57,100 |
|
|
|
54,913 |
|
|
Rent received in advance and tenant security deposits |
|
|
50,060 |
|
|
|
50,307 |
|
|
Other liabilities |
|
|
10,746 |
|
|
|
10,698 |
|
|
Total liabilities |
|
|
499,440 |
|
|
|
522,854 |
|
|
Commitments and contingencies |
|
|
|
|
||||
|
Stockholders’ equity: |
|
|
|
|
||||
|
Preferred stock, par value |
|
|
108,081 |
|
|
|
47,780 |
|
|
Common stock, par value |
|
|
28 |
|
|
|
28 |
|
|
Additional paid-in capital |
|
|
2,123,710 |
|
|
|
2,113,184 |
|
|
Dividends in excess of earnings |
|
|
(337,279 |
) |
|
|
(312,988 |
) |
|
Total stockholders’ equity |
|
|
1,894,540 |
|
|
|
1,848,004 |
|
|
Total liabilities and stockholders’ equity |
|
$ |
2,393,980 |
|
|
$ |
2,370,858 |
|
|
CONSOLIDATED STATEMENTS OF INCOME
For the Three Months Ended (Unaudited) (In thousands, except share and per share amounts) |
||||||||
|
|
|
For the Three Months Ended
|
||||||
|
|
|
2026 |
|
2025 |
||||
|
Revenues: |
|
|
|
|
||||
|
Rental (including tenant reimbursements) |
|
$ |
68,920 |
|
|
$ |
71,697 |
|
|
Other |
|
|
76 |
|
|
|
25 |
|
|
Total revenues |
|
|
68,996 |
|
|
|
71,722 |
|
|
|
|
|
|
|
||||
|
Expenses: |
|
|
|
|
||||
|
Property expenses |
|
|
7,576 |
|
|
|
7,379 |
|
|
General and administrative expense |
|
|
10,349 |
|
|
|
8,461 |
|
|
Depreciation and amortization expense |
|
|
18,584 |
|
|
|
18,391 |
|
|
Impairment loss on real estate |
|
|
— |
|
|
|
3,527 |
|
|
Total expenses |
|
|
36,509 |
|
|
|
37,758 |
|
|
Gain (loss) on sale of real estate |
|
|
422 |
|
|
|
— |
|
|
Income from operations |
|
|
32,909 |
|
|
|
33,964 |
|
|
Interest and other income |
|
|
6,331 |
|
|
|
1,613 |
|
|
Interest expense |
|
|
(6,431 |
) |
|
|
(4,500 |
) |
|
Net income |
|
|
32,809 |
|
|
|
31,077 |
|
|
Preferred stock dividends |
|
|
(2,654 |
) |
|
|
(781 |
) |
|
Net income attributable to common stockholders |
|
$ |
30,155 |
|
|
$ |
30,296 |
|
|
Net income attributable to common stockholders per share: |
|
|
|
|
||||
|
Basic |
|
$ |
1.04 |
|
|
$ |
1.05 |
|
|
Diluted |
|
$ |
1.02 |
|
|
$ |
1.03 |
|
|
Weighted-average shares outstanding: |
|
|
|
|
||||
|
Basic |
|
|
27,991,910 |
|
|
|
28,275,549 |
|
|
Diluted |
|
|
28,467,184 |
|
|
|
28,588,022 |
|
|
FFO, NORMALIZED FFO AND AFFO
For the Three Months Ended (Unaudited) (In thousands, except share and per share amounts) |
||||||||
|
|
|
For the Three Months Ended
|
||||||
|
|
|
2026 |
|
2025 |
||||
|
Net income attributable to common stockholders |
|
$ |
30,155 |
|
|
$ |
30,296 |
|
|
Real estate depreciation and amortization |
|
|
18,584 |
|
|
|
18,391 |
|
|
Impairment loss on real estate |
|
|
— |
|
|
|
3,527 |
|
|
Loss (gain) on sale of real estate |
|
|
(422 |
) |
|
|
— |
|
|
FFO attributable to common stockholders (basic and diluted) |
|
|
48,317 |
|
|
|
52,214 |
|
|
Litigation-related expense |
|
|
1,870 |
|
|
|
406 |
|
|
Loss (gain) on partial repayment of Notes due 2026 |
|
|
— |
|
|
|
(32 |
) |
|
Income on seller-financed notes(1) |
|
|
223 |
|
|
|
153 |
|
|
Deferred lease payments received on sales-type leases(2) |
|
|
175 |
|
|
|
20 |
|
|
Normalized FFO attributable to common stockholders (diluted) |
|
|
50,585 |
|
|
|
52,761 |
|
|
Stock-based compensation |
|
|
2,584 |
|
|
|
2,078 |
|
|
Non-cash interest expense |
|
|
576 |
|
|
|
470 |
|
|
Non-cash accretion of life science investments |
|
|
(334 |
) |
|
|
— |
|
|
Above-market lease amortization |
|
|
23 |
|
|
|
23 |
|
|
AFFO attributable to common stockholders (diluted) |
|
$ |
53,434 |
|
|
$ |
55,332 |
|
|
FFO per common share – diluted |
|
$ |
1.70 |
|
|
$ |
1.83 |
|
|
Normalized FFO per common share – diluted |
|
$ |
1.78 |
|
|
$ |
1.85 |
|
|
AFFO per common share – diluted |
|
$ |
1.88 |
|
|
$ |
1.94 |
|
|
Weighted average common shares outstanding – basic |
|
|
27,991,910 |
|
|
|
28,275,549 |
|
|
Restricted stock and RSUs |
|
|
475,274 |
|
|
|
312,473 |
|
|
Weighted average common shares outstanding – diluted |
|
|
28,467,184 |
|
|
|
28,588,022 |
|
|
____________________________________________________________________ |
||
|
(1) |
Amount reflects non-refundable cash payments received pursuant to seller-financed notes issued by us in connection with our disposition of certain properties. As the transactions did not qualify for recognition as completed sales under GAAP, the payments are recorded as a deposit liability and included in other liabilities on our consolidated balance sheet. |
|
|
(2) |
Amount reflects the non-refundable lease payments received on two sales-type leases which are recognized as a deposit liability starting on |
|
Non-GAAP Financial Measures
Funds From Operations (FFO)
FFO and FFO per share are operating performance measures adopted by the
Management believes that net income, as defined by GAAP, is the most appropriate earnings measurement. However, management believes FFO and FFO per share to be supplemental measures of a REIT’s performance because they provide an understanding of the operating performance of IIP's properties without giving effect to certain significant non-cash items, primarily depreciation expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. IIP believes that by excluding the effect of depreciation, FFO and FFO per share can facilitate comparisons of operating performance between periods. IIP reports FFO and FFO per share because these measures are observed by management to also be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because FFO per share is consistently reported, discussed, and compared by research analysts in their notes and publications about REITs. For these reasons, management has deemed it appropriate to disclose and discuss FFO and FFO per share.
Normalized Funds from Operations (Normalized FFO)
IIP computes Normalized FFO by adjusting FFO, as defined by NAREIT, to exclude certain GAAP income and expense amounts that management believes are infrequent and unusual in nature and/or not related to IIP's core real estate operations. Exclusion of these items from similar FFO-type metrics is common within the equity REIT industry, and management believes that presentation of Normalized FFO and Normalized FFO per share provides investors with a metric to assist in their evaluation of IIP's operating performance across multiple periods and in comparison to the operating performance of other companies, because it removes the effect of unusual items that are not expected to impact IIP's operating performance on an ongoing basis. Normalized FFO is used by management in evaluating the performance of IIP's core business operations.
Adjusted Funds from Operations (AFFO)
Management believes that AFFO and AFFO per share are also appropriate supplemental measures of a REIT’s operating performance. IIP calculates AFFO by adjusting Normalized FFO for certain non-cash items.
IIP’s computation of FFO, Normalized FFO and AFFO may differ from the methodology for calculating FFO, Normalized FFO and AFFO utilized by other equity REITs and, accordingly, may not be comparable to such REITs. Further, FFO, Normalized FFO and AFFO do not represent cash flow available for management’s discretionary use. FFO, Normalized FFO and AFFO should not be considered as an alternative to net income (computed in accordance with GAAP) as an indicator of IIP’s financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of IIP’s liquidity, nor is it indicative of funds available to fund IIP’s cash needs, including IIP’s ability to pay dividends or make distributions. FFO, Normalized FFO and AFFO should be considered only as supplements to net income computed in accordance with GAAP as measures of IIP’s operations.
Definitions
Debt
: Calculated as the sum of the carrying value of the Notes due 2026 and the Revolving Credit Facilities, as presented on IIP's consolidated balance sheet as of
Gross Assets: Calculated as total assets plus accumulated depreciation, as presented on IIP's consolidated balance sheet as of
View source version on businesswire.com: https://www.businesswire.com/news/home/20260504110176/en/
Company Contact:
Chief Financial Officer
(858) 997-3332
Source: